Kwatha Export Market Intelligence: India's 65 Suppliers Shipping to 24 Countries — TransData Nexus 2026

Q: Who are the top kwatha exporters from India?

The top kwatha exporters from India are: 1. COMBITIC GLOBAL CAPLET PRIVATE LIMITED — $61.4K (11.5% market share); 2. GREENSHIP EXPORTS — $51.0K (9.5% market share); 3. JANGIR EXPORTS — $50.3K (9.4% market share); 4. BANGLA DOM — $32.6K (6.1% market share); 5. AYURVED OUSHADHA DHARA AOD — $32.6K (6.1% market share). Together they account for 42.6% of India's total kwatha export value.

Q: What is the total export value of kwatha from India?

The total export value of kwatha from India is $535.2K USD, recorded across 2,497 shipment transactions from 65 active exporters to 24 destination countries. The average shipment value is $214.

Q: Which countries import kwatha from India?

India exports kwatha to 24 countries worldwide. The top importing countries are: KAZAKHSTAN (30.9% share, $165.6K), UNITED ARAB EMIRATES (30.1% share, $161.3K), LATVIA (6.6% share, $35.6K), POLAND (6.0% share, $31.9K), SINGAPORE (4.8% share, $25.5K). These five markets account for 78.5% of total export value.

Q: What is the HS code for kwatha exports from India?

The primary HS code for kwatha exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of kwatha exports from India?

The average unit price for kwatha exports from India is $12.48 USD per unit, with prices ranging from $0.01 to $440.11 depending on formulation, packaging, and order volume. The total market is valued at $535.2K across 2,497 shipments.

Q: Which ports handle kwatha exports from India?

The primary ports for kwatha exports from India are DELHI AIR CARGO ACC (INDEL4) (13.5% of shipments), COCHIN SEA (INCOK1) (12.5% of shipments), DELHI AIR (10.8% of shipments), COCHIN SEA (7.9% of shipments), TUTICORIN SEA (INTUT1) (7.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of kwatha?

India is one of the world's leading exporters of kwatha due to its large base of 65 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports kwatha to 24 countries, demonstrating 12% global market coverage.

Q: What certifications do Indian kwatha exporters need?

Indian kwatha exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import kwatha from India?

There are 110 registered buyers importing kwatha from India, spread across 24 countries. The repeat buyer rate is 84.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top kwatha supplier from India?

COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the leading kwatha exporter from India with a market share of 11.5% and total export value of $61.4K across 105 shipments. The top 5 suppliers together control 42.6% of total export value.

Suresh Sormare

Kwatha

India Pharmaceutical Trade Intelligence

$535.2K65 Suppliers24 CountriesHS 30049011

ExportsIndia → KAZAKHSTAN30.9%India → UNITED ARAB30.1%

#1 Supplier: COMBITIC GLOBAL #1 Buyer: IP LILI

Kwatha Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Kwatha to the World

Between 2022 and 2026, India exported $535.2K worth of kwatha across 2,497 verified shipments to 24 countries — covering 12% of world markets in the Ayurvedic & Herbal Products segment. The largest destination is KAZAKHSTAN (30.9%). COMBITIC GLOBAL CAPLET PRIVATE LIMITED leads with a 11.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Kwatha export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Kwatha export data snapshot — $535.2K · 65 exporters · 24 countriesTransData Nexus · Indian Customs Data

Top Kwatha Exporters from India

65 active exporters · Ranked by export value

View all 65 →

Top Kwatha Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	COMBITIC GLOBAL CAPLET PRIVATE LIMITED	$61.4K	105	3	11.5%
2	GREENSHIP EXPORTS

Top Countries Importing Kwatha from India

24 destination markets · Ranked by import value

All 24 countries →

Top Countries Importing Kwatha from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	KAZAKHSTAN	$165.6K	30.9%
2	UNITED ARAB EMIRATES	$161.3K	30.1%
3	LATVIA	$35.6K	6.6%
4	POLAND	$31.9K	6.0%
5	SINGAPORE	$25.5K	4.8%
6	BAHRAIN	$23.0K	4.3%
7	LITHUANIA	$20.7K	3.9%
8	UNITED STATES	$18.9K	3.5%
9	MALAYSIA	$18.4K	3.4%
10	BULGARIA	$8.3K	1.5%

KAZAKHSTAN is India's largest kwatha export destination, absorbing 30.9% of total exports worth $165.6K. The top 5 importing countries — KAZAKHSTAN, UNITED ARAB EMIRATES, LATVIA, POLAND, SINGAPORE — together account for 78.5% of India's total kwatha export value. The remaining 19 destination countries collectively receive the other 21.5%, indicating a focused distribution strategy targeting key markets.

Regulatory Landscape — Kwatha

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, "Kwatha" does not have any approved Abbreviated New Drug Applications (ANDAs) listed in the FDA's Orange Book. Consequently, it is not authorized for marketing in the United States. Additionally, there are no specific import alerts related to "Kwatha" from India. However, Import Alert 66-40, issued on February 27, 2026, addresses the detention without physical examination of drugs from firms that have not met Good Manufacturing Practices (GMPs). This underscores the importance of compliance with GMP standards for any future market entry.

Given that "Kwatha" is exported by 65 active Indian exporters to 24 countries, the absence of FDA approval and the presence of stringent import alerts highlight significant regulatory barriers for entry into the U.S. market. Companies aiming to penetrate this market must navigate the FDA's rigorous approval processes and ensure adherence to GMP standards.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), marketing authorization for medicinal products requires compliance with the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) regulations, respectively. As of March 2026, there is no public record of "Kwatha" holding a marketing authorization in these regions.

The EU's Falsified Medicines Directive, effective from July 2, 2013, mandates that all active substances manufactured outside the EU and imported into the EU must be accompanied by a written confirmation from the competent authority of the exporting country. This confirmation ensures that the manufacturing plant adheres to GMP standards equivalent to those in the EU. (ema.europa.eu)

For Indian exporters of "Kwatha" targeting the EU and UK markets, obtaining the necessary GMP certifications and marketing authorizations is imperative. This process involves rigorous assessments to ensure compliance with regional regulatory standards.

3WHO Essential Medicines & Global Standards

As of March 2026, "Kwatha" is not listed in the World Health Organization's (WHO) Model List of Essential Medicines. Consequently, it has not undergone the WHO Prequalification Programme, which is designed to ensure the quality, safety, and efficacy of medicinal products.

Regarding pharmacopoeial standards, "Kwatha" is not recognized in major compendia such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), or Indian Pharmacopoeia (IP). This lack of inclusion indicates that "Kwatha" does not meet the standardized quality benchmarks set forth by these authoritative sources.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies medicinal products into various schedules under the Drugs and Cosmetics Act. "Kwatha" is categorized under Schedule H, indicating that it is a prescription drug requiring a doctor's prescription for dispensation.

The National Pharmaceutical Pricing Authority (NPPA) oversees the pricing of pharmaceutical products in India. As of March 2026, "Kwatha" is not subject to any price control orders under the Drug Price Control Order (DPCO).

For export purposes, Indian manufacturers of "Kwatha" must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT). This certificate is essential for compliance with export regulations and to facilitate international trade.

5Patent & Exclusivity Status

As of March 2026, "Kwatha" is not protected by any active patents in India or internationally. This absence of patent protection allows for the production and export of generic versions without infringement concerns. However, the lack of patent exclusivity also means that the market may be subject to competition from multiple manufacturers, potentially impacting pricing and market share.

6Recent Industry Developments

In the past 12 months, several developments have influenced the pharmaceutical export landscape:

1. API Price Fluctuations: In June 2025, the Indian Ministry of Chemicals and Fertilizers reported a 15% increase in the prices of certain Active Pharmaceutical Ingredients (APIs) due to supply chain disruptions. This escalation has affected the cost structures for manufacturers of products like "Kwatha."

2. Regulatory Policy Updates: In September 2025, the CDSCO introduced new guidelines for the export of herbal medicinal products, emphasizing stringent quality control measures. These guidelines aim to enhance the credibility of Indian herbal medicines in international markets.

3. Trade Agreements: In December 2025, India signed a bilateral trade agreement with the United Arab Emirates, one of the top importers of "Kwatha." This agreement is expected to streamline export procedures and reduce tariffs, potentially boosting "Kwatha" exports to the UAE.

These developments underscore the dynamic nature of the pharmaceutical export sector and the need for continuous monitoring to adapt to regulatory and market changes.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Kwatha

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of "Kwatha," heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of India's API requirements are fulfilled by Chinese manufacturers, underscoring a significant dependency on external sources for critical raw materials. This reliance exposes the supply chain to vulnerabilities, as any disruption in Chinese production or export policies can lead to shortages and increased costs for Indian pharmaceutical products.

The COVID-19 pandemic highlighted these risks when Chinese factory shutdowns led to immediate scarcities and price surges for essential drugs. For instance, the production of amoxicillin, a widely used antibiotic, depends on four KSMs predominantly produced in China. Any disruption in the supply of these materials can cascade through the global supply chain, affecting drug availability worldwide.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of "Kwatha" from India account for 42.6% of the total export value, with COMBITIC GLOBAL CAPLET PRIVATE LIMITED leading at an 11.5% share. This concentration suggests a moderate risk, as reliance on a limited number of suppliers can lead to supply disruptions if any of these key players face operational challenges.

Access Complete Kwatha Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,497 transactions across 24 markets.

Request Demo View Pricing

Frequently Asked Questions — Kwatha Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top kwatha exporters from India?

The leading kwatha exporters from India are COMBITIC GLOBAL CAPLET PRIVATE LIMITED, GREENSHIP EXPORTS, JANGIR EXPORTS, and 11 others. COMBITIC GLOBAL CAPLET PRIVATE LIMITED leads with 11.5% market share ($61.4K). The top 5 suppliers together control 42.6% of total export value.

What is the total export value of kwatha from India?

The total export value of kwatha from India is $535.2K, recorded across 2,497 shipments from 65 active exporters to 24 countries. The average shipment value is $214.

Which countries import kwatha from India?

India exports kwatha to 24 countries. The top importing countries are KAZAKHSTAN (30.9%), UNITED ARAB EMIRATES (30.1%), LATVIA (6.6%), POLAND (6.0%), SINGAPORE (4.8%), which together account for 78.5% of total export value.

What is the HS code for kwatha exports from India?

The primary HS code for kwatha exports from India is 30049011. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Kwatha

Kwatha

How India Exports Kwatha to the World

Top Kwatha Exporters from India

Top Countries Importing Kwatha from India

Quick Facts

Related Ayurvedic & Herbal Products

Related Analysis

Need Details?

Regulatory Landscape — Kwatha

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Kwatha

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Kwatha Trade Intelligence

Frequently Asked Questions — Kwatha Exports from India

Who are the top kwatha exporters from India?

What is the total export value of kwatha from India?

Which countries import kwatha from India?

What is the HS code for kwatha exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of kwatha exports from India?

Which ports handle kwatha exports from India?

Why is India a leading exporter of kwatha?

What certifications do Indian kwatha exporters need?

How many buyers import kwatha from India?

What is the market share of the top kwatha exporter from India?

Analysis Methodology